Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools

BESSO MJ; MONTIVERO, LUCIANA; LACUNZA; E; ARGIBAY, MARIA CECILIA; ABBA, M; FURLONG LI; COLAS, E; GIL-MORENO, ANTONIO; REVENTOS, JAUME; VAZQUEZ LEVIN, M.H.

ONCOLOGY REPORTS

SPANDIDOS PUBL LTD

Lugar: Atenas; Año: 2020 vol. 44 p. 873 - 886

1021-335X

Endometrial cancer (EC) is the sixth most common cancer in women worldwide. Early diagnosis is critical in recurrent EC management. The present study aimed to identify biomarkers of EC early recurrence using a workflow that combined text and data mining databases (DisGeNET, Gene Expression Omnibus), a prioritization algorithm to select a set of putative candidates (ToppGene), protein‑protein interaction network analyses (Search Tool for the Retrieval of Interacting Genes, cytoHubba), association analysis of selected genes with clinicopathological parameters, and survival analysis (Kaplan‑Meier and Cox proportional hazard ratio analyses) using a The Cancer Genome Atlas cohort. A total of 10 genes were identified, among which the targeting protein for Xklp2 (TPX2) was the most promising independent prognostic biomarker in stage I EC. TPX2 expression (mRNA and protein) was higher (P